Average Co-Inventor Count = 3.86
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (29 from 2,405 patents)
2. Merck + Co., Inc. (15 from 4,770 patents)
3. Msd R&d Co., Ltd. (0 patent)
44 patents:
1. 12331018 - Pyrrolidine orexin receptor agonists
2. 11066396 - 3-aryl- heteroaryl substituted 5-trifluoromethyl oxadiazoles as histonedeacetylase 6 (HDAC6) inhibitors
3. 10556900 - TrkA kinase inhibitors, compositions and methods thereof
4. 9914736 - TrKA kinase inhibitors, compositions and methods thereof
5. 9896447 - TrkA kinase inhibitors, compositions and methods thereof
6. 9862716 - TRKA kinase inhibitors, compositions and methods thereof
7. 9815846 - TrkA kinase inhibitors, compositions and methods thereof
8. 9718782 - TrkA kinase inhibitors, compositions and methods thereof
9. 9550786 - 4-fluoropiperidine orexin receptor antagonists
10. 8778957 - CGRP receptor antagonists
11. 8765759 - Monocyclic CGRP receptor antagonists
12. 8569291 - Bicyclic dihydroimidazolone CGRP receptor antagonists
13. 8507477 - 3- and 6-quinolines with N-attached heterocyclic CGRP receptor antagonists
14. 8173655 - Bicyclic anilide heterocyclic CGRP receptor antagonists
15. 8163752 - Tricyclic anilide heterocyclic CGRP receptor antagonists